Scarica l'app Stockscreener
1.94
5.37%
-0.11
Dopo l'orario di chiusura:
1.91
-0.03
-1.55%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$2.05
Aprire:
$2.05
Volume 24 ore:
98,813
Relative Volume:
0.44
Capitalizzazione di mercato:
$32.69M
Reddito:
-
Utile/perdita netta:
$-52.53M
Rapporto P/E:
-0.5301
EPS:
-3.66
Flusso di cassa netto:
$-39.93M
1 W Prestazione:
-11.42%
1M Prestazione:
+8.38%
6M Prestazione:
+26.80%
1 anno Prestazione:
+10.86%
Intervallo 1D:
$1.94
$2.13
Intervallo di 1 settimana:
$1.94
$2.33
Portata 52W:
$0.9397
$3.10
Unity Biotechnology Inc Stock (UBX) Company Profile
Nome
Unity Biotechnology Inc
Settore
Industria
Telefono
(650) 416-1192
Indirizzo
285 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA
Confronta UBX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
UBX
Unity Biotechnology Inc
|
1.94 | 32.69M | 0 | -52.53M | -39.93M | -3.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Unity Biotechnology Inc Stock (UBX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-22 | Iniziato | Rodman & Renshaw | Buy |
| 2023-11-16 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2022-01-04 | Aggiornamento | ROTH Capital | Neutral → Buy |
| 2021-11-10 | Aggiornamento | Mizuho | Neutral → Buy |
| 2021-06-28 | Aggiornamento | Citigroup | Sell → Buy |
| 2021-06-07 | Iniziato | H.C. Wainwright | Buy |
| 2021-02-16 | Downgrade | Citigroup | Neutral → Sell |
| 2020-08-18 | Downgrade | Citigroup | Buy → Neutral |
| 2020-08-18 | Downgrade | Mizuho | Buy → Neutral |
| 2020-08-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-08-17 | Downgrade | ROTH Capital | Buy → Neutral |
| 2020-07-28 | Iniziato | ROTH Capital | Buy |
| 2019-12-12 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-03-07 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-09-07 | Iniziato | Mizuho | Buy |
| 2018-05-29 | Iniziato | Citigroup | Buy |
| 2018-05-29 | Iniziato | Goldman | Neutral |
| 2018-05-29 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Unity Biotechnology Inc Borsa (UBX) Ultime notizie
Unity Biotechnology CEO Anirvan Ghosh sells shares worth $1,431 - MSN
Unity Biotechnology CFO sells shares worth $341 - Investing.com India
Unity Biotechnology CFO sells shares worth $341 By Investing.com - Investing.com Nigeria
Unity Biotechnology CEO Anirvan Ghosh sells shares worth $1,431 By Investing.com - Investing.com Nigeria
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
UBX stock touches 52-week high at $2.02 amid market optimism - MSN
Adversity is less terrifying than hope: Unity Biotechnology Inc (UBX) - SETE News
70+ Key Companies Advancing in Dry Age-Related Macular Degeneration Clinical Trial Therapeutic Space | DelveInsight - PR Newswire UK
UBX stock touches 52-week high at $2.02 amid market optimism By Investing.com - Investing.com South Africa
Research Analysts Offer Predictions for UBX FY2024 Earnings - Defense World
Geode Capital Management LLC Buys 14,199 Shares of Unity Biotechnology, Inc. (NASDAQ:UBX) - Defense World
Unity Biotechnology (NASDAQ:UBX) Coverage Initiated at Chardan Capital - Defense World
Chardan initiates Unity Biotechnology stock with Buy rating, cites senolytic UBX1325 potential - Investing.com India
UBXUnity Biotechnology, Inc. Latest Stock News & Market Updates - StockTitan
Unity Biotechnology (NASDAQ:UBX) Shares Down 26.5% – Here’s What Happened - Defense World
Pre-market Movers: SANA, SLDB, JSPR, DRIO... - RTTNews
UNITY Biotechnology Reports Granting of New Employment Inducement Award - GlobeNewswire
UNITY Biotechnology Announces Appointment of Federico Grossi, M.D., Ph.D., as Chief Medical Officer - GlobeNewswire
UNITY Biotech appoints new chief medical officer - Investing.com
UNITY Biotech Appoints SYFOVRE Developer Dr. Grossi as CMO Ahead of Key DME Trial Results - StockTitan
Unity Biotechnology, Inc. (NASDAQ:UBX): Is Breakeven Near? - Simply Wall St
We're Keeping An Eye On Unity Biotechnology's (NASDAQ:UBX) Cash Burn Rate - Yahoo Finance
Ten Levels of Longevity: #5 aging disease management - Longevity.Technology
Unity Biotechnology stock hits 52-week low at $0.94 By Investing.com - Investing.com Canada
Unity Biotechnology stock hits 52-week low at $0.94 - Investing.com India
Unity Biotechnology stock hits 52-week low at $0.95 By Investing.com - Investing.com Nigeria
Unity Biotechnology stock hits 52-week low at $0.95 - Investing.com
Unity Biotechnology (NASDAQ:UBX) Trading Down 5.6% – What’s Next? - Defense World
Unity Biotechnology stock hits 52-week low at $1.1 - Investing.com
Unity Biotechnology stock hits 52-week low at $1.1 By Investing.com - Investing.com UK
Unity Biotechnology stock hits 52-week low at $1.1 amid challenges - Investing.com Canada
Unity Biotechnology (FRA:9U90) EV-to-Revenue : (As of Dec. 05, 2024) - GuruFocus.com
Unity Biotechnology (STU:9U90) EV-to-Revenue : (As of Nov. 28, 2024) - GuruFocus.com
Finance Watch: Adcendo Pursues Proof-Of-Concept With $135m Series B Round - Citeline
Unity Biotechnology (FRA:9U90) Price-to-Operating-Cash-Flow : (As of Nov. 25, 2024) - GuruFocus.com
Frazier Life Sciences Appoints John Smither and Jim Williams as Senior Advisors - BioSpace
Alyeska Investment Group L.P.'s Strategic Acquisition in Unity B - GuruFocus.com
Pre-market Movers: REVB, CDIO, SMLR, DWTX... - RTTNews
Unity Biotechnology Inc Azioni (UBX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Unity Biotechnology Inc Azioni (UBX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Nguyen Alexander Hieu | CLO and Head of Ops |
Feb 04 '25 |
Sale |
2.23 |
164 |
366 |
24,559 |
| Ghosh Anirvan | Chief Executive Officer |
Feb 04 '25 |
Sale |
2.23 |
642 |
1,432 |
75,251 |
| Ghosh Anirvan | Chief Executive Officer |
Nov 04 '24 |
Sale |
1.29 |
432 |
557 |
75,893 |
| Sullivan Lynne Marie | CFO & Head of Corp. Dev. |
Nov 04 '24 |
Sale |
1.29 |
136 |
175 |
55,925 |
| Nguyen Alexander Hieu | Chief Legal Officer |
Nov 04 '24 |
Sale |
1.29 |
149 |
192 |
24,723 |
| Nguyen Alexander Hieu | Chief Legal Officer |
Aug 02 '24 |
Sale |
1.53 |
154 |
236 |
24,872 |
| Ghosh Anirvan | Chief Executive Officer |
Aug 02 '24 |
Sale |
1.53 |
604 |
924 |
76,325 |
| Sullivan Lynne Marie | CFO & Head of Corp. Dev. |
Aug 02 '24 |
Sale |
1.53 |
139 |
213 |
56,061 |
| Nguyen Alexander Hieu | Chief Legal Officer |
Jun 25 '24 |
Sale |
1.40 |
78 |
109 |
25,026 |
| Ghosh Anirvan | Chief Executive Officer |
Jun 25 '24 |
Sale |
1.40 |
1,214 |
1,700 |
76,929 |
0.27%
3.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):